Dealing with health threats
MEDICAL reports show that diabetics have higher risks of brain cell damage, leading to the formation of lesions at the white matter area of the brain, called white matter lesion.
The extent of this predicts the cognitive functions of the brain increase risks of dementia, Alzheimer’s and major strokes.
If you have both diabetes and hypertension, your risk in getting silent strokes rises rapidly to 82%, meaning the extent of brain cell damage will increase yearly.
Currently, there are no medical treatments for silent stroke damages.
Medical treatment will only be rendered when symptoms of dementia, Alzheimer’s or stroke prevails, which may be too late for preventive treatment.
The most common cause of kidney failure is due to diabetes complication – 10% to 40% of those with Type 2 diabetes eventually suffer from kidney failure.
High blood glucose or blood sugar can damage the blood vessels in your kidneys.
Many people with diabetes also develop high blood pressure, which can damage kidneys.
The current medical recommendation for reducing the progression of kidney damage is to gain good control of your blood sugar.
Recent increasing interests in the medical benefits of palm tocotrienols have led to the publications in several medical journals on the promising outcome of palm tocotrienols in addressing diabetes complications.
Studies on how palm tocotrienols work on the vital cells in the brain, nerve and kidney show that it exerts strong protective and recovery actions to the cells.
With its 60 times more potent antioxidant effects as compared to the conventional vitamin E and with multiple anti-inflammatory properties, palm tocotrienols help shield and protect cells from damage caused by high sugar levels, called glycation.
From stroke studies, it can be clearly seen that palm tocotrienols exert a unique arteriogenesis effect by redirecting peripheral small blood reperfusion to the damaged areas so it can regain blood and oxygen supply quickly to minimise further cell death.
Even though palm tocotrienols belong to the vitamin E family, its properties are only found in palm tocotrienols and not in other forms of vitamin E.
Palm tocotrienols, by nature, is known to be poorly absorbed into the human body.
Therefore, all clinical studies conducted used the palm tocotrienols in Suprabio technology to ensure the body gets enough palm tocotrienols for a beneficial effect.
It is a self-emulsifying delivery system proven to deliver accurately and 300 times more pharmaceutical dosage of palm tocotrienols to the vital organs to exert its therapeutic effects on the brain, nerves and kidney.
Suprabio is a patented pharmaceutical technology founded and patented by Hovid.